Vascular Smooth Muscle Cells (VSMC) Proliferation of Streptozotocin-Diabetic Animals Induced by Diadenosine Polyphosphates

Experimental and Clinical Endocrinology and Diabetes

Volumn 112, Issue 3, 2004, Pages 142-147

  Verspohl, E J ^a   Hagemann, J ^a   Lempka, M ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Diadenosine polyphosphates; Proliferation; Streptozotocin diabetic animals; VSMC

Indexed keywords

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; DIADENOSINE POLYPHOSPHATE; DIADENOSINE POLYPHOSPHATE AP4A; DIADENOSINE POLYPHOSPHATE AP5A; DIADENOSINE POLYPHOSPHATE AP6A; PURINE P2X RECEPTOR; PURINE P2Y APXA RECEPTOR; PURINE P2Y RECEPTOR; PURINE P2Y1 RECEPTOR; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; STREPTOZOCIN; SURAMIN; UNCLASSIFIED DRUG;

ANIMAL CELL; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BINDING SITE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; HYPERGLYCEMIA; NONHUMAN; PRIORITY JOURNAL; RAT; RISK FACTOR; STREPTOZOCIN DIABETES; VASCULAR SMOOTH MUSCLE;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL CULTURE TECHNIQUES; CELL DIVISION; DIABETES MELLITUS, EXPERIMENTAL; DINUCLEOSIDE PHOSPHATES; DNA REPLICATION; KINETICS; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, WISTAR; THYMIDINE; URIDINE TRIPHOSPHATE;

EID: 1842481315     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-817823     Document Type: Article

References (33)

1. Blackburn GM, Taylor GE, Thatcher GR, Prescott M, McLennan AG. Synthesis and resistance to enzymic hydrolysis of stereochemically-defined phosphonate and thiophosphate analogs of P1,P4-bis(5′-adenosyl) tetraphosphate. Nucleic Acids Res 1987; 15: 6991-7004
2. Chen ZP, Krull N, Xu S, Levy A, Lightman SL. Molecular cloning and functional characterization of a rat pituitary G protein-coupled adenosine triphosphate (ATP) receptor. Endocrinology 1996; 137: 1833-1840
3. Davies G, MacAllister RJ, Bogle RG, Vallance P. Effects of diadenosine polyphosphates on human umbilical vessels: novel platelet-derived vasoconstrictors. Br J Clin Pharmacol 1995; 40: 170-172
4. Dubey RK, Gillespie DG, Osaka K, Suzuki F, Jackson EK. Adenosine inhibits growth of rat aortic smooth muscle cells. Possible role of A2b receptor. Hypertension 1996; 27: 786-793
5. 4A) to rat liver cell membranes. Biochem J 1996; 314: 687-693
6. Erlinge D. Extracellular ATP: a growth factor for vascular smooth muscle cells. Gen Pharmacol 1998; 31: 1-8
7. Erlinge D, You J, Wahlestedt C, Edvinsson L. Characterisation of an ATP receptor mediating mitogenesis in vascular smooth muscle cells. Eur J Pharmacol 1995; 289: 135-149
8. 4-tetraphosphate. J Biol Chem 1991; 266: 6915-6918
9. 2-purinoceptors in the guinea-pig left atrium by diadenosine polyphosphates. Br J Pharmacol 1996; 118: 1294-1301
10. 2G in releasable granules of platelets. J Biol Chem 2001; 279: 8904-8909.
11. Kawano M, Koshikawa T, Kanazaki T, Morisaki N, Saito Y, Yoshida S. Diabetes mellitus induces accelerated growth of aortic smooth muscle cells: association with overexpression of PDGF beta-receptors. Eur J Clin Invest 1993; 23: 84-90
12. Lazarowski ER, Watt WC, Stutts MJ, Boucher RC, Harden TK. Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate. Br J Pharmacol 1995; 116: 1619-1627
13. Meyer-Lehnert H, Schrier RW. Potential mechanism of cyclosporine A-induced vascular muscle contraction. Hypertension Dallas 1989; 13: 352-360
14. Ogilvie A, Blasius R, Schulze-Lohoff E, Sterzel RB. Adenine dinucleotides: a novel class of signalling molecules. J Auton Pharmacol 1996; 16: 325-328
15. Parés-Herbuté N, Hillaire-Buys D, Etienne P, Gross R, Loubatieres-Mariani MM, Monnier L. Adenosine inhibitory effect on enhanced growth of aortic smooth muscle cells from streptozotocin-induced diabetic rats. Br J Pharmacol 1996; 118: 783-789.
16. Rice WR, Burton FM, Fiedeldey DT. Cloning and expression of the alveolar type 11 cell P2U - purinergic receptor. Am J Respir Cell Mol Biol 1995; 12: 27-32
17. 3H]diadenosine tetraphosphate binding sites in rat brain. Neuroscience 1997; 77: 247-255
18. Rupprecht HD, Dann P, Sukhatme VP, Sterzel RB, Coleman DL. Effect of vasoactive agents on induction of Egr-1 in rat mesangial cells: correlation with mitogenicity. Am J Physiol 1992; 263: F623-636
19. Schlüter H, Offers E, Brüggemann G, van der Giet M, Tepel M, Nordhoff E, Karas M, Spieker C, Witzel H, Zidek W. Diadenosine phosphates and the physiological control of blood pressure. Nature 1994; 367: 187-188
20. Schlüter H, Tepel M, Zidek W. Vascular actions of diadenosine polyphosphates. J Autonomic Pharmacology 1996; 16: 357-362
21. Schulze-Lohoff E, Zanner S, Ogilvie A, Sterzel RB. Vasoactive diadenosine polyphosphates promote growth of cultured renal mesangial cells. Hypertension 1995; 26: 899-904
22. Sukhatme VP, Cao XM, Chang LC, Tsai-Morris CH, Stamenkovich D, Ferreira PC, Cohen DR, Edwards SA, Shows TB, Curran T. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 1988; 53: 37-73
23. Tepel M, Bachmann J, Schlüter H, Zidek W. Diadenosine polyphosphate-induced increase in cytosolic free calcium in vascular smooth muscle cells. J Hypertension 1995; 13: 1686-1688
24. Tepel M, Bachmann J, Schlüter H, Zidek W. Diadenosine polyphosphates increase cytosolic calcium and attenuate angiotensin-11-induced changes of calcium in vascular smooth muscle cells. J Vasc Res 1996; 33: 132-138
25. Tepel M, Jankowski J, Schlüter H, Bachmann J, van der Giet M, Rüss C, Terliesner J, Zidek W. Diadenosine polyphosphates' action on calcium and vessel contraction. Am J Hypertens 1997; 10: 1404-1410
26. 1-adenosine receptors. Br J Pharmacol 1996; 119: 835-844
27. Verspohl EJ, Johannwille B. Diadenosine polyphosphates in insulin-secreting cells: Interaction with specific receptors and degradation. Diabetes 1998; 47: 1727-1734
28. Verspohl EJ, Johannwille B, Kaiserling-Buddemeier I, Schlüter H, Hagemann J. Diadenosine polyphosphates in cultured vascular smooth muscle cells and endothelium cells-their interaction with specific receptors and their degradation. J Pharm Pharmacol 1999; 51: 1175-1181
29. 4A) induces a diabetogenic situation: its impact on blood glucose, plasma insulin, gluconeogenesis, glucose uptake and GLUT-4 transporters. Die Pharmazie 2003a; 58: 910-915
30. Verspohl EJ, Schülter H, Zidek W. Long-term effects of diadenosine polyphosphates on blood pressure, heart rate, glucose and insulin levels of rats. Medicinal Chemistry Research 2003 b (in press)
31. 4-tetraphosphate receptor is at the cell surface of heart cells. Biochemistry 1993; 32: 14009-14014
32. Wang R, Kudo M, Naito Z, Yokoyama M, Yamada N, Asano G. Effects of serum of streptozotocin-induced diabetic rats on vascular smooth muscle cell growth in vitro. Nippon Ika Daigaku Zasshi Aug 1998; 65: 284-290
33. Yu SM, Chen SF, Lau YT, Yang CM, Chen JC. Mechanism of extracellular ATP-induced proliferation of vascular smooth muscle cells. Mol Pharmacol 1996; 50: 1000-1009